EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 22.75
+1.40 (6.56%)
Nov 4, 2026, 5:29 PM CET
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 671.8 million as of November 4, 2026. It is the 28,095th most valuable company in the world and the 356th biggest in Sweden. Its market cap has decreased by 63.31% in one year.
Market Cap
671.80M
Enterprise Value
1.07B
Revenue
432.35M
Global Rank
Country Rank
#356 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 671.80M, an increase of 758.83%. That is a compound annual growth rate of 18.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 671.80M | -60.64% |
| Dec 30, 2025 | 1.71B | -27.50% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.97B |
| Dicot Pharma AB | 757.56M |
| Cereno Scientific AB | 647.70M |
| Cinclus Pharma Holding AB | 557.52M |
| Enzymatica AB | 551.01M |
| Moberg Pharma AB | 519.93M |
| Orexo AB | 173.49M |
| Klaria Pharma Holding AB (publ.) | 132.58M |